Scarica l'app Stockscreener
59.85
3.25%
-2.01
Precedente Chiudi:
$61.86
Aprire:
$61.86
Volume 24 ore:
1.08M
Relative Volume:
1.22
Capitalizzazione di mercato:
$5.31B
Reddito:
$5.07M
Utile/perdita netta:
$-186.75M
Rapporto P/E:
-25.55
EPS:
-2.3424
Flusso di cassa netto:
$-160.43M
1 W Prestazione:
-6.22%
1M Prestazione:
-19.25%
6M Prestazione:
-9.78%
1 anno Prestazione:
+43.01%
Intervallo 1D:
$59.37
$62.00
Intervallo di 1 settimana:
$59.37
$64.15
Portata 52W:
$35.80
$80.97
Cg Oncology Inc Stock (CGON) Company Profile
Nome
Cg Oncology Inc
Settore
Industria
Telefono
(949) 409-3700
Indirizzo
3000 PEGASUS PARK DRIVE, DALLAS
Compare CGON vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
59.85 | 5.31B | 5.07M | -186.75M | -160.43M | -2.3424 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-19 | Iniziato | Wolfe Research | Peer Perform |
| 2025-12-11 | Iniziato | Wedbush | Outperform |
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-05-02 | Iniziato | JP Morgan | Overweight |
| 2025-04-16 | Iniziato | Scotiabank | Sector Perform |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-09-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2024-06-28 | Iniziato | BofA Securities | Buy |
| 2024-02-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-20 | Iniziato | Goldman | Neutral |
| 2024-02-20 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-14 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Cg Oncology Inc Borsa (CGON) Ultime notizie
A director plans to sell 3,000 shares of CG Oncology (NASDAQ: CGON). - Stock Titan
Form DEF 14A CG Oncology Inc For: 11 October By Investing.com - Investing.com India
After $7.9M sale, CG Oncology (NASDAQ: CGON) officer plans more stock trades - Stock Titan
CG Oncology (Nasdaq:CGON)Stock Analysis - Simply Wall Street
CG Oncology (NASDAQ: CGON) director sells shares under preset trading plan - Stock Titan
CGON Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Costs Weigh on Results - careplusvn.com
CGON Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Costs Weigh on ResultsEPS Guidance Update - dars.gov.et
CG Oncology (NASDAQ: CGON) officer sold 100,000 shares and now plans more - Stock Titan
Planned CG Oncology (NASDAQ: CGON) insider sale totals 826 shares - Stock Titan
CG Oncology at Cantor conference: cretostimogene nears key readout By Investing.com - Investing.com Canada
CG Oncology at Cantor conference: cretostimogene nears key readout By Investing.com - Investing.com India
CG Oncology at Cantor conference: cretostimogene nears key readout By Investing.com - Investing.com Nigeria
Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)? - Zacks Investment Research
CG Oncology (CGON) Stock Looks Fully Priced After A 160% Run - Yahoo Finance
CG Oncology (CGON) officer to sell 29,630 shares after prior 100K trades - Stock Titan
CG Oncology to Present at Upcoming Investor Conferences in September - manilatimes.net
CG Oncology to Present at Upcoming Investor Conferences in September - marketscreener.com
Morgan Stanley and Cantor Fitzgerald conferences will include talks by CG Oncology’s CEO in New York. - Stock Titan
Bank of New York Mellon Corp Invests $16.58 Million in CG Oncology, Inc. $CGON - marketbeat.com
CG Oncology (NASDAQ: CGON) officer lines up new sale after $7.9M August trades - Stock Titan
CG Oncology (NASDAQ: CGON) holder plans 5,789-share sale from option exercise - Stock Titan
ADAR1 Capital Management LLC Invests $8.43 Million in CG Oncology, Inc. $CGON - MarketBeat
Regulatory Momentum Around Oncolytic Virus Therapy Could Be A Game Changer For CG Oncology (CGON) - sahmcapital.com
CG Oncology (NASDAQ: CGON) officer eyes new sale after $7.9M August stock trade - Stock Titan
CG Oncology (NASDAQ: CGON) officer plans new sale after $7.95M August trade - Stock Titan
RTW INVESTMENTS, LP Boosts CG Oncology Inc (CGON) Stake -- Shares Look 38% Undervalued on GF Value - GuruFocus
Jefferies Group's CG Oncology Inc(CGON) Holding History - GuruFocus
Investigation launched into CG Oncology officers for possible self-dealing harming shareholders - Pluang
Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm - PR Newswire
How Investors May Respond To CG Oncology (CGON) Revenue Growth Alongside a Widening Net Loss - simplywall.st
How Investors May Respond To CG Oncology (CGON) Revenue Growth Alongside a Widening Net Loss - simplywall.st
CG Oncology (NASDAQ: CGON) insider flags $7.95M stock sale after recent disposals - Stock Titan
CG Oncology stock hits all-time high of 79.5 USD By Investing.com - Investing.com Nigeria
CG Oncology stock hits all-time high of 79.5 USD By Investing.com - Investing.com Canada
CG Oncology stock hits all-time high of 79.5 USD By Investing.com - Investing.com South Africa
CG Oncology stock hits all-time high of 79.5 USD By Investing.com - Investing.com South Africa
CG Oncology stock hits all-time high of 79.5 USD - Investing.com
CG Oncology (NASDAQ:CGON) Flaunts a Perfect Technical Breakout Setup - ChartMill
CG (CGON) Financial Update: EPS Misses Its Estimate in the Reported Period; Share Move: The Stock Ends Up 5.75% at the CloseQuarterly Earnings - careplusvn.com
CG Oncology director sells 1,000 shares at $74.54 | CGON Insider Trading - Stock Titan
CG Oncology (NASDAQ: CGON) insider lines up new stock sale - Stock Titan
CGON shareholder (NASDAQ: CGON) details planned 19,364-share stock sale - Stock Titan
CG Oncology (CGON) sees Foresite Capital report 4.9% beneficial stake via funds - Stock Titan
CG Oncology (CGON): RTW Investments takes 9.7% position, holding 8.5M shares - Stock Titan
CG Oncology's bladder cancer drug shows strong results with 75% response rate and no severe side effects. - Pluang
CG Oncology: Circling Back After Huge Rally - Seeking Alpha
CGON (CGON) investor lists 25,989-share sale after series of stock disposals - Stock Titan
CG Oncology (CGON) Falls 2.96% as Shares Approach Key Support at $70.97Institutional Volume - Vinanet
CG Oncology (CGON): Wellington group discloses 5.3M-share, 6.04% ownership position - Stock Titan
CG Oncology (CGON) Falls 2.96% as Shares Approach Key Support at $70.97Rounding Bottom - siam.in
Cg Oncology Inc Azioni (CGON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cg Oncology Inc Azioni (CGON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| AMBAW BELLETE | Officer |
Sep 21 '26 |
Proposed Sale |
76.01 |
30,787 |
2,340,024 |
0 |
| AMBAW BELLETE | Officer |
Sep 17 '26 |
Proposed Sale |
76.50 |
6,532 |
499,698 |
0 |
| POST LEONARD E | Director |
Sep 15 '26 |
Option Exercise |
0.60 |
1,000 |
600 |
1,000 |
| POST LEONARD E | Director |
Sep 15 '26 |
Sale |
72.98 |
1,000 |
72,980 |
0 |
| AMBAW BELLETE | Officer |
Sep 11 '26 |
Proposed Sale |
75.00 |
826 |
61,950 |
0 |
| AMBAW BELLETE | Officer |
Sep 02 '26 |
Proposed Sale |
77.61 |
29,630 |
2,299,448 |
0 |
| AMBAW BELLETE | Officer |
Aug 31 '26 |
Proposed Sale |
75.50 |
50,000 |
3,775,250 |
0 |
| AMBAW BELLETE | Officer |
Aug 27 '26 |
Proposed Sale |
79.39 |
5,789 |
459,561 |
0 |
| AMBAW BELLETE | Officer |
Aug 25 '26 |
Proposed Sale |
79.55 |
10,551 |
839,338 |
0 |
| AMBAW BELLETE | Officer |
Aug 24 '26 |
Proposed Sale |
79.52 |
5,762 |
458,185 |
0 |
2.69%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):